These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35385733)

  • 41. Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer.
    Chen S; He Y; Huang X; Shen Y; Zou Q; Yang G; Fu L; Liu Q; Luo D
    J Nanobiotechnology; 2024 Jun; 22(1):348. PubMed ID: 38898486
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development.
    Zhang C; Wei S; Dai S; Li X; Wang H; Zhang H; Sun G; Shan B; Zhao L
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37217247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapy.
    Li J; Ma A; Zhang R; Chen Y; Bolyard C; Zhao B; Wang C; Pich T; Li W; Sun N; Ma Q; Wen H; Clinton SK; Carson WE; Li Z; Xin G
    Cancer Immunol Immunother; 2024 Feb; 73(3):52. PubMed ID: 38349405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeted co-delivery of resiquimod and a SIRPα variant by liposomes to activate macrophage immune responses for tumor immunotherapy.
    Jia D; Lu Y; Lv M; Wang F; Lu X; Zhu W; Wei J; Guo W; Liu R; Li G; Wang R; Li J; Yuan F
    J Control Release; 2023 Aug; 360():858-871. PubMed ID: 37473808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. NF-κB: Governing Macrophages in Cancer.
    Cornice J; Verzella D; Arboretto P; Vecchiotti D; Capece D; Zazzeroni F; Franzoso G
    Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-associated macrophages: The key player in hepatoblastoma microenvironment and the promising therapeutic target.
    Adawy A; Komohara Y; Hibi T
    Microbiol Immunol; 2024 Aug; 68(8):249-253. PubMed ID: 38923004
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Supramolecular nanotherapeutics enable metabolic reprogramming of tumor-associated macrophages to inhibit tumor growth.
    Ramesh A; Malik V; Brouillard A; Kulkarni A
    J Biomed Mater Res A; 2022 Aug; 110(8):1448-1459. PubMed ID: 35388955
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism in tumour-associated macrophages: a
    Zheng X; Mansouri S; Krager A; Grimminger F; Seeger W; Pullamsetti SS; Wheelock CE; Savai R
    Eur Respir Rev; 2020 Sep; 29(157):. PubMed ID: 33004525
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multi-Omics Analysis Showed the Clinical Value of Gene Signatures of C1QC
    Li X; Zhang Q; Chen G; Luo D
    Front Immunol; 2021; 12():694801. PubMed ID: 34295336
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phagocytosis of Glioma Cells Enhances the Immunosuppressive Phenotype of Bone Marrow-Derived Macrophages.
    Wu M; Wu L; Wu W; Zhu M; Li J; Wang Z; Li J; Ding R; Liang Y; Li L; Zhang T; Huang B; Cai Y; Li K; Li L; Zhang R; Hu B; Lin F; Wang X; Zheng S; Chen J; You Y; Jiang T; Zhang J; Chen H; Wang Q
    Cancer Res; 2023 Mar; 83(5):771-785. PubMed ID: 36622331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting tumor-associated macrophages with mannosylated nanotherapeutics delivering TLR7/8 agonist enhances cancer immunotherapy.
    Dang BN; Duwa R; Lee S; Kwon TK; Chang JH; Jeong JH; Yook S
    J Control Release; 2024 Aug; 372():587-608. PubMed ID: 38942083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Integrative single-cell transcriptomic analyses reveal the cellular ontological and functional heterogeneities of primary and metastatic liver tumors.
    Gui M; Huang S; Li S; Chen Y; Cheng F; Liu Y; Wang JA; Wang Y; Guo R; Lu Y; Cao P; Zhou G
    J Transl Med; 2024 Feb; 22(1):206. PubMed ID: 38414027
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status.
    Dallavalasa S; Beeraka NM; Basavaraju CG; Tulimilli SV; Sadhu SP; Rajesh K; Aliev G; Madhunapantula SV
    Curr Med Chem; 2021; 28(39):8203-8236. PubMed ID: 34303328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of macrophages in the tumor microenvironment and tumor metabolism.
    Sadhukhan P; Seiwert TY
    Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Macrophage xCT deficiency drives immune activation and boosts responses to immune checkpoint blockade in lung cancer.
    Tang B; Wang Y; Xu W; Zhu J; Weng Q; Chen W; Fang S; Yang Y; Qiu R; Chen M; Mao W; Xu M; Zhao Z; Cai S; Zhang H; Ji J
    Cancer Lett; 2023 Feb; 554():216021. PubMed ID: 36455758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coculturing liver cancer cells and monocytes in spheroids conditions monocytes to adopt tumor-associated macrophage phenotypes that favor tumor growth via cholesterol metabolism.
    Keawvilai P; Kueanjinda P; Klomsing J; Palaga T
    J Leukoc Biol; 2024 Jan; 115(2):344-357. PubMed ID: 37742062
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor microenvironment-responsive macrophage-mediated immunotherapeutic drug delivery.
    Zhang X; Yue L; Cao L; Liu K; Yang S; Liang S; Liu L; Zhao C; Wu D; Wang Z; Tian R; Rao L
    Acta Biomater; 2024 Sep; 186():369-382. PubMed ID: 39097127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies.
    Bai R; Li Y; Jian L; Yang Y; Zhao L; Wei M
    Mol Cancer; 2022 Sep; 21(1):177. PubMed ID: 36071472
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy.
    Wang X; Xu Y; Sun Q; Zhou X; Ma W; Wu J; Zhuang J; Sun C
    Biomed Pharmacother; 2022 Sep; 153():113343. PubMed ID: 35785706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.